NCT02128906
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02128906
Title Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christopher Wilke
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.